No OTC Sildenafil In Germany After Committee Rejects All Rx-To-OTC Switches

The German Expert Committee for Prescription has rejected the Rx-to-OTC reclassifications of sildenafil (50mg) for oral use and xylometazoline and ipratropium bromide for intranasal use. 

Denied_Stamp
• Source: Shutterstock

Erectile dysfunction drug sildenafil will not be available in Germany without a prescription any time soon, after the country’s reclassification committee rejected all tabled Rx-to-OTC switches at its last sitting.

Alongside xylometazoline and ipratropium bromide combinations for intranasal use, the German Expert Committee for Prescription at its 25 January meeting...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography